STOCK TITAN

Brooks to Participate in Stephens Annual Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

CHELMSFORD, Mass., Nov. 18, 2021 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Stephens Annual Investment Conference on Friday, December 3, 2021 which includes a webcast beginning at 1:00 p.m. CT.  The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events.  A replay of the webcast will be available following the event.

About Brooks Automation
Brooks (Nasdaq: BRKS) is a leading provider of life sciences solutions worldwide. The Life Sciences business, recently rebranded as Azenta Life Sciences, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As announced at its recent investor day, Brooks Automation, Inc, currently trading on Nasdaq under the ticker symbol BRKS, is changing its name to Azenta, Inc. and will begin trading on Nasdaq under the ticker symbol AZTA, effective at the open of market trading on December 1, 2021.

In addition, the company operates the Semiconductor Solutions Group business, an industry-leading provider of semiconductor manufacturing automation and collaborative robotics solutions worldwide. On September 20, 2021, the Company announced the pending sale of this business to Thomas H. Lee Partners. Due to the pending divestiture, the Company began reporting the Semiconductor Solutions Group business as discontinued operations in its recent fiscal year-end earnings announcement. 

Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.brooks.com and www.azenta.com

INVESTOR CONTACTS:

Sara Silverman
Director, Investor Relations
Brooks Automation
978.262.2635
sara.silverman@brooks.com

Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com 

(PRNewsfoto/Brooks Automation)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/brooks-to-participate-in-stephens-annual-investment-conference-301428587.html

SOURCE Brooks Automation

brks

NASDAQ:BRKS

BRKS Rankings

BRKS Latest News

BRKS Stock Data

Semiconductor and Related Device Manufacturing
Manufacturing
Link
US
Chelmsford

About BRKS

Brooks Automation Inc. is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europeand Asia.